Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Bicycle Therapeutics (BCYC) Receivables - Other (2019 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Receivables - Other for 6 consecutive years, with $67.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables - Other changed N/A year-over-year to $67.3 million, compared with a TTM value of $67.3 million through Sep 2025, changed N/A, and an annual FY2024 reading of $35.7 million, changed N/A over the prior year.
  • Receivables - Other was $67.3 million for Q3 2025 at Bicycle Therapeutics, up from $60.8 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $67.3 million in Q3 2025 and bottomed at $7.7 million in Q3 2021.
  • Average Receivables - Other over 4 years is $28.9 million, with a median of $14.3 million recorded in 2021.
  • Peak annual rise in Receivables - Other hit 47.56% in 2022, while the deepest fall reached 15.59% in 2022.
  • Year by year, Receivables - Other stood at $10.9 million in 2021, then grew by 4.2% to $11.4 million in 2022, then surged by 213.63% to $35.7 million in 2024, then surged by 88.66% to $67.3 million in 2025.
  • Business Quant data shows Receivables - Other for BCYC at $67.3 million in Q3 2025, $60.8 million in Q2 2025, and $46.2 million in Q1 2025.